Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide (Q42493038)

1 November 2017

Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide (English)

1 reference

1 November 2017

1 reference

Masaaki Kobayashi

1

1 reference

1 November 2017

Manabu Takeuchi

2

1 reference

1 November 2017

Satoru Hashimoto

3

1 reference

1 November 2017

Ken-ichi Mizuno

4

1 reference

1 November 2017

Yuichi Sato

5

1 reference

1 November 2017

Rintaro Narisawa

6

1 reference

1 November 2017

Yutaka Aoyagi

7

1 reference

1 November 2017

13 August 2011

1 reference

Digestive Diseases and Sciences

1 November 2017

1 reference

1 November 2017

57

1 reference

1 November 2017

119-126

1 reference

1 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-011-1850-4

1 November 2017

0 references

cites work

Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Effect of a Proton Pump Inhibitor or an H2-Receptor Antagonist on Prevention of Bleeding From Ulcer After Endoscopic Submucosal Dissection of Early Gastric Cancer: A Prospective Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1850-4

Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils

21 January 2018

1 reference

12 December 2020

Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial

1 reference

12 December 2020

Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection

1 reference

12 December 2020

Helicobacter pylori eradication restored sonic hedgehog expression in the stomach

1 reference

12 December 2020

Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers

1 reference

12 December 2020

10.1007/S10620-011-1850-4

Identifiers

DOI

1 reference

1 November 2017

1 reference